176 related articles for article (PubMed ID: 37092726)
1. Human DUX4 and mouse Dux interact with STAT1 and broadly inhibit interferon-stimulated gene induction.
Spens AE; Sutliff NA; Bennett SR; Campbell AE; Tapscott SJ
Elife; 2023 Apr; 12():. PubMed ID: 37092726
[TBL] [Abstract][Full Text] [Related]
2. Canine DUXC: implications for DUX4 retrotransposition and preclinical models of FSHD.
Wong CJ; Whiddon JL; Langford AT; Belleville AE; Tapscott SJ
Hum Mol Genet; 2022 May; 31(10):1694-1704. PubMed ID: 34888646
[TBL] [Abstract][Full Text] [Related]
3. Human DUX4 and porcine DUXC activate similar early embryonic programs in pig muscle cells: implications for preclinical models of FSHD.
Nip Y; Bennett SR; Smith AA; Jones TI; Jones PL; Tapscott SJ
Hum Mol Genet; 2023 May; 32(11):1864-1874. PubMed ID: 36728804
[TBL] [Abstract][Full Text] [Related]
4. p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models.
Grow EJ; Weaver BD; Smith CM; Guo J; Stein P; Shadle SC; Hendrickson PG; Johnson NE; Butterfield RJ; Menafra R; Kloet SL; van der Maarel SM; Williams CJ; Cairns BR
Nat Genet; 2021 Aug; 53(8):1207-1220. PubMed ID: 34267371
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity.
Jones TI; Chew GL; Barraza-Flores P; Schreier S; Ramirez M; Wuebbles RD; Burkin DJ; Bradley RK; Jones PL
Skelet Muscle; 2020 Apr; 10(1):8. PubMed ID: 32278354
[TBL] [Abstract][Full Text] [Related]
6. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.
Snider L; Geng LN; Lemmers RJ; Kyba M; Ware CB; Nelson AM; Tawil R; Filippova GN; van der Maarel SM; Tapscott SJ; Miller DG
PLoS Genet; 2010 Oct; 6(10):e1001181. PubMed ID: 21060811
[TBL] [Abstract][Full Text] [Related]
7. DUX4-Induced Histone Variants H3.X and H3.Y Mark DUX4 Target Genes for Expression.
Resnick R; Wong CJ; Hamm DC; Bennett SR; Skene PJ; Hake SB; Henikoff S; van der Maarel SM; Tapscott SJ
Cell Rep; 2019 Nov; 29(7):1812-1820.e5. PubMed ID: 31722199
[TBL] [Abstract][Full Text] [Related]
8. The evolution of DUX4 gene regulation and its implication for facioscapulohumeral muscular dystrophy.
Jagannathan S
Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166367. PubMed ID: 35158020
[TBL] [Abstract][Full Text] [Related]
9. Direct interplay between two candidate genes in FSHD muscular dystrophy.
Ferri G; Huichalaf CH; Caccia R; Gabellini D
Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
[TBL] [Abstract][Full Text] [Related]
10. Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4.
Eidahl JO; Giesige CR; Domire JS; Wallace LM; Fowler AM; Guckes SM; Garwick-Coppens SE; Labhart P; Harper SQ
Hum Mol Genet; 2016 Oct; 25(20):4577-4589. PubMed ID: 28173143
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor DUX4 orchestrates translational reprogramming by broadly suppressing translation efficiency and promoting expression of DUX4-induced mRNAs.
Hamm DC; Paatela EM; Bennett SR; Wong CJ; Campbell AE; Wladyka CL; Smith AA; Jagannathan S; Hsieh AC; Tapscott SJ
PLoS Biol; 2023 Sep; 21(9):e3002317. PubMed ID: 37747887
[TBL] [Abstract][Full Text] [Related]
12. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle.
Yao Z; Snider L; Balog J; Lemmers RJ; Van Der Maarel SM; Tawil R; Tapscott SJ
Hum Mol Genet; 2014 Oct; 23(20):5342-52. PubMed ID: 24861551
[TBL] [Abstract][Full Text] [Related]
13. Influence of
Duranti E; Villa C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298453
[TBL] [Abstract][Full Text] [Related]
14. DUX4 expression in cancer induces a metastable early embryonic totipotent program.
Smith AA; Nip Y; Bennett SR; Hamm DC; Lemmers RJLF; van der Vliet PJ; Setty M; van der Maarel SM; Tapscott SJ
Cell Rep; 2023 Sep; 42(9):113114. PubMed ID: 37691147
[TBL] [Abstract][Full Text] [Related]
15. DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis.
Young JM; Whiddon JL; Yao Z; Kasinathan B; Snider L; Geng LN; Balog J; Tawil R; van der Maarel SM; Tapscott SJ
PLoS Genet; 2013 Nov; 9(11):e1003947. PubMed ID: 24278031
[TBL] [Abstract][Full Text] [Related]
16. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.
Banerji CRS; Zammit PS
EMBO Mol Med; 2021 Aug; 13(8):e13695. PubMed ID: 34151531
[TBL] [Abstract][Full Text] [Related]
17. Conservation and innovation in the DUX4-family gene network.
Whiddon JL; Langford AT; Wong CJ; Zhong JW; Tapscott SJ
Nat Genet; 2017 Jun; 49(6):935-940. PubMed ID: 28459454
[TBL] [Abstract][Full Text] [Related]
18. MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy.
Runfola V; Giambruno R; Caronni C; Pannese M; Andolfo A; Gabellini D
Cell Rep; 2023 Sep; 42(9):113120. PubMed ID: 37703175
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
Haynes P; Kernan K; Zhou SL; Miller DG
Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
[TBL] [Abstract][Full Text] [Related]
20. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy.
Geng LN; Yao Z; Snider L; Fong AP; Cech JN; Young JM; van der Maarel SM; Ruzzo WL; Gentleman RC; Tawil R; Tapscott SJ
Dev Cell; 2012 Jan; 22(1):38-51. PubMed ID: 22209328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
